We then explored the protective role of GSTA1 for hepatic steatosis in mice induced by HFD for 16 weeks with an injection of adeno-associated virus 8 (AAV8) overexpressing GSTA1 (AAV8-Gsta1) at week 8 (Figure 4A). Here, GSTA1 is linked to fatty liver disease.